Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ ERBB2 -Altered Advanced Biliary Tract Cancers.

Autor:	Zeme EL; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA., Van Loon K; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, CA., Kelley RK; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, CA., Gordan JD; University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, CA.
Jazyk:	angličtina
Zdroj:	Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 20; Vol. 42 (27), pp. 3170-3176. Date of Electronic Publication: 2024 Aug 05.
DOI:	10.1200/JCO.24.00868
Abstrakt:	The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology , to patients seen in their own clinical practice.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu